Genmab reported its First Quarter 2013 financial results after market close on May 7. Click here to listen to the webcast. Click here to download slides.
Updated data from the Phase I/II study of daratumumab in refractory multiple myeloma was presented at the 14th International Myeloma Workshop in Kyoto, Japan on April 4. Click here to view the poster.
Genmab has launched a new website dedicated to its DuoBody® technology platform. Visit the new site at www.DuoBody.com. We have also recently published key scientific research on DuoBody, Click here to read the article.